Back to Search Start Over

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

Authors :
Tettero, Jesse M
Ngai, Lok Lam
Bachas, Costa
Breems, Dimitri A
Fischer, Thomas
Gjertsen, Bjorn T
Gradowska, Patrycja
Griskevicius, Laimonas
Janssen, Jeroen J W M
Juliusson, Gunnar
Maertens, Johan
Manz, Markus G; https://orcid.org/0000-0002-4676-7931
Pabst, Thomas
Passweg, Jakob
Porkka, Kimmo
Valk, Peter J M; https://orcid.org/0000-0002-8857-9461
Löwenberg, Bob; https://orcid.org/0000-0001-8982-5217
Ossenkoppele, Gert J
Cloos, Jacqueline
Tettero, Jesse M
Ngai, Lok Lam
Bachas, Costa
Breems, Dimitri A
Fischer, Thomas
Gjertsen, Bjorn T
Gradowska, Patrycja
Griskevicius, Laimonas
Janssen, Jeroen J W M
Juliusson, Gunnar
Maertens, Johan
Manz, Markus G; https://orcid.org/0000-0002-4676-7931
Pabst, Thomas
Passweg, Jakob
Porkka, Kimmo
Valk, Peter J M; https://orcid.org/0000-0002-8857-9461
Löwenberg, Bob; https://orcid.org/0000-0001-8982-5217
Ossenkoppele, Gert J
Cloos, Jacqueline
Source :
Tettero, Jesse M; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Gradowska, Patrycja; Griskevicius, Laimonas; Janssen, Jeroen J W M; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Valk, Peter J M; Löwenberg, Bob; Ossenkoppele, Gert J; Cloos, Jacqueline (2023). Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival. Haematologica, 108(10):2794-2798.
Publication Year :
2023

Details

Database :
OAIster
Journal :
Tettero, Jesse M; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Gradowska, Patrycja; Griskevicius, Laimonas; Janssen, Jeroen J W M; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Valk, Peter J M; Löwenberg, Bob; Ossenkoppele, Gert J; Cloos, Jacqueline (2023). Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival. Haematologica, 108(10):2794-2798.
Notes :
application/pdf, info:doi/10.5167/uzh-239008, English, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1443054057
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details